AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development
AGC INC UNSP/ADR (ASGLY)
NASDAQ:AMEX Investor Relations:
newsquantified.com/asgly/sec-filings-report/agc-american-depositary-receipts-unsponsored-form-f6-incadr-filed-bank-05ks9e
Company Research
Source: Business Wire
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)--As drug developers face increasing pressure to lower prices and accelerate time to market, global biopharmaceutical contract development and manufacturing organization AGC Biologics is expanding its Cell Line Development Center of Excellence by partnering with ATUM to integrate the Leap-In Transposase® expression platform within its offerings. This partnership provides drug developers with technology designed to increase yields and significantly shorten the path to clinical trials, directly addressing the market’s need for speed and efficiency.With ATUM’s modern transposase-based platform now available through AGC Biologics, the CDMO offers a range of cell line development options to meet diverse customer needs, from complex molecules requiring rapid development to more straightforward projects where
Show less
Read more
Impact Snapshot
Event Time:
ASGLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASGLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASGLY alerts
High impacting AGC INC UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ASGLY
News
- AGC Biologics to expand cell line development with ATUM partnership [Yahoo! Finance]Yahoo! Finance
- AGC Biologics to Manufacture AAVantgarde's Dual-Vector Gene Therapies for Inherited Retinal Disorders [Yahoo! Finance]Yahoo! Finance
- AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal DisordersBusiness Wire
- AGC???????????·??????????????????????????mRNA????????? [CNET News]CNET News
- AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality [Yahoo! Finance]Yahoo! Finance